1. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer;Chiba;Oncogene,1990
2. Growth suppression of human head and neck cancer cells by the introduction of a wildtype p53 gene via a recombinant adenovirus;Liu;Cancer Res,1994
3. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer;Wills;Hum Gene Ther,1994
4. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer;Eastham;Cancer Res,1995
5. Enhancement of gene transduction in human carcinoma cells by DNA-damaging agents;Nguyen;Proc Am Assoc Cancer Res,1996